ES2049999T3 - Empleo de hidroxido de zinc-calcio, lecitina y pao para coadyuvar soluciones de antigenos, y soluciones de antigenos coadyuvadas de esta forma. - Google Patents

Empleo de hidroxido de zinc-calcio, lecitina y pao para coadyuvar soluciones de antigenos, y soluciones de antigenos coadyuvadas de esta forma.

Info

Publication number
ES2049999T3
ES2049999T3 ES91103258T ES91103258T ES2049999T3 ES 2049999 T3 ES2049999 T3 ES 2049999T3 ES 91103258 T ES91103258 T ES 91103258T ES 91103258 T ES91103258 T ES 91103258T ES 2049999 T3 ES2049999 T3 ES 2049999T3
Authority
ES
Spain
Prior art keywords
antigen solutions
lecithin
zinc
calcium hydroxide
coadyuvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91103258T
Other languages
English (en)
Inventor
Dieter Dr Bernhardt
Joachim Dr Hilfenhaus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of ES2049999T3 publication Critical patent/ES2049999T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

SE DESCRIBE UN METODO PARA LA COMPLEMENTACION DE SOLUCIONES DE ANTIGENO EN LA QUE SE DA UN GEL DE HIDROXIDO DE ZINC Y DE HIDROXIDO DE CALCIO Y, DADO EL CASO, ADEMAS UNA LECITINA Y ADICIONALMENTE UNA POLIALFAOLICINICA.
ES91103258T 1990-03-08 1991-03-05 Empleo de hidroxido de zinc-calcio, lecitina y pao para coadyuvar soluciones de antigenos, y soluciones de antigenos coadyuvadas de esta forma. Expired - Lifetime ES2049999T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4007315A DE4007315A1 (de) 1990-03-08 1990-03-08 Verwendung von zink-calciumhydroxid, lecithin und pao zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen

Publications (1)

Publication Number Publication Date
ES2049999T3 true ES2049999T3 (es) 1994-05-01

Family

ID=6401694

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91103258T Expired - Lifetime ES2049999T3 (es) 1990-03-08 1991-03-05 Empleo de hidroxido de zinc-calcio, lecitina y pao para coadyuvar soluciones de antigenos, y soluciones de antigenos coadyuvadas de esta forma.

Country Status (12)

Country Link
US (1) US5232690A (es)
EP (1) EP0445710B1 (es)
JP (1) JP3018256B2 (es)
KR (1) KR100195571B1 (es)
AT (1) ATE101045T1 (es)
AU (1) AU653331B2 (es)
CA (1) CA2037709C (es)
DE (2) DE4007315A1 (es)
DK (1) DK0445710T3 (es)
ES (1) ES2049999T3 (es)
IE (1) IE65211B1 (es)
PT (1) PT96959B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4333376C2 (de) * 1993-09-30 1995-09-07 Gerbu Biotechnik Gmbh Mittel zur Steigerung der Ausbeute von Antikörpern in der Immunologie
US6764682B1 (en) * 1994-06-16 2004-07-20 Aventis Pasteur Limited Adjuvant compositions containing more than one adjuvant
DK0789590T3 (da) * 1994-09-23 2002-11-04 Zonagen Inc Chitosaninduceret immunforstærkning
US6290971B1 (en) 1995-06-15 2001-09-18 Aventis Pasteur Limited Adjuvant compositions comprising a mineral salt and another immunostimulating compound
FR2754182B1 (fr) * 1996-10-07 1998-11-06 Seppic Sa Nouvelles compositions vaccinales comportant comme adjuvant un compose sympathomimetique
GB9924351D0 (en) * 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
US20020051794A1 (en) 2000-08-09 2002-05-02 Alk-Abello A/S Novel parenteral vaccine formulations and uses thereof
AU7960101A (en) * 2000-08-09 2002-02-18 Alk Abello As Parenteral vaccine formulations and uses thereof
WO2002069985A2 (en) * 2001-03-05 2002-09-12 Forinnova As Immune response potentiation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
FR2466991A1 (fr) * 1979-10-08 1981-04-17 Pasteur Institut Perfectionnement a la preparation d'allergene
DE3241113A1 (de) * 1982-11-06 1984-05-10 Bayer Ag, 5090 Leverkusen Vakzinen mit zuschlagstoffen
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4803070A (en) * 1986-04-15 1989-02-07 Ribi Immunochem Research Inc. Immunological emulsion adjuvants for polysaccharide vaccines
DE3817531A1 (de) * 1988-05-24 1989-12-07 Behringwerke Ag Antigenloesung enthaltend ein polyalphaolefin (pao), verfahren ihrer herstellung und die verwendung von pao als adjuvans
DE3834729A1 (de) * 1988-10-12 1990-04-19 Behringwerke Ag Verwendung von zink-oder eisenhydroxid zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen

Also Published As

Publication number Publication date
IE65211B1 (en) 1995-10-04
PT96959B (pt) 1998-07-31
PT96959A (pt) 1991-12-31
DK0445710T3 (da) 1994-06-06
CA2037709C (en) 2002-02-26
IE910757A1 (en) 1991-09-11
KR910016342A (ko) 1991-11-05
KR100195571B1 (ko) 1999-06-15
JPH04217631A (ja) 1992-08-07
JP3018256B2 (ja) 2000-03-13
AU7271291A (en) 1991-09-12
EP0445710B1 (de) 1994-02-02
DE4007315A1 (de) 1991-09-12
AU653331B2 (en) 1994-09-29
CA2037709A1 (en) 1991-09-09
US5232690A (en) 1993-08-03
ATE101045T1 (de) 1994-02-15
EP0445710A1 (de) 1991-09-11
DE59100964D1 (de) 1994-03-17

Similar Documents

Publication Publication Date Title
ES2158842T3 (es) Grapa quirurgica polimera.
ES2157958T3 (es) Uso de venlafaxina o de un compuesto de ariloxipropanamina para la preparacion de un medicamento para el tratamiento de la incontinencia urinaria.
ES2081411T3 (es) Procedimiento para la obtencion de poliisobuteno.
BR9407544A (pt) Artigo absorvente
ES2031806T3 (es) Factor de permeabilidad vascular humano.
BR9306683A (pt) Adesivo proteináceo curado com aldeído
FI912490A0 (fi) Kollagenas-inhibitorer baserade pao hydroxamsyror.
AR038434A2 (es) Compuesto 14,15-dihidro-16-oxoparahercuamida y compuestos 2-desoxo de parahercuamida y marcfortina
DE68920985D1 (de) Durchsichtige, holografische Bremsleuchte mit Fernbeleuchtung.
ES2134468T3 (es) Preparado de colageno para la liberacion controlada de principios activos.
FI894804A0 (fi) Anvaendning av zink- och jaernhydroxid som adjuvanter av antigenloesningar och pao detta saett effektiverade antigenloesningar.
ES2083656T3 (es) Procedimiento para la obtencion de 1,2-propilenglicol.
ES2186807T3 (es) Inhibidores de trombina.
ES2186235T3 (es) Recubrimiento lubricante para dispositivos medicos.
ES1013655Y (es) Dispositivo para la simulacion de un cielo estrellado fijo con iluminacion artificial.
MX9705806A (es) Forma farmaceutica destinada a la cesion de colagenasa en heridas, y procedimiento para su elaboracion.
DK0445710T3 (da) Anvendelse af zink-calciumhydroxid, lecithin og PAO til adjuvering af antigenopløsninger og på denne måde adjuverede antigenopløsninger
ES2056812T5 (es) Uso de una inmunoglobulina marcada detectablemente o un fragmento de la misma en la fabricacion de un agente para la deteccion de un sitio de inflamacion in vivo.
ES2053718T3 (es) Metodo para la deteccion de hongos en alimentos y cuerpos fluidos animales y humanos.
EA199700449A1 (ru) Способ предотвращения остеопороза
ES2149257T3 (es) Procedimiento para la preparacion de 10-desacetoxibaccatina iii y 10-desacetoxitaxol y sus derivados.
ES2066253T3 (es) Procedimiento para la reticulacion de polimeros que contienen halogeno.
ES2066739B1 (es) Inmunoensayo para analitos en muestras empleando agentes alquilantes.
YU48719B (sh) Lizin so 6-hloro-5-fluoro-3-(2-tenoil)-2-oksindol-1-karboksamida
ES2105290T3 (es) Composicion herbicida.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 445710

Country of ref document: ES